Hjem › Mage-tarmkreft › Texas › Houston
Kliniske studier for Mage-tarmkreft i Houston, TX
21 studier for Mage-tarmkreft søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RekruttererFase 3
- GSK Investigational Site, Houston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- Oncology Consultants P.A., Houston
- Oncology Consultants P.A., Houston
- Texas Oncology - Gulf Coast, Houston
- og 7 flere
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekruttererFase 1/2
- Baylor College of Medicine, Houston
- The University of Texas MD Anderson Cancer Center, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- MD Anderson, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
RekruttererFase 1/2
- GSK Investigational Site, Houston
Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers
RekruttererObservasjonsstudie
- M D Anderson Cancer Center, Houston
Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
Rekrutterer
- MD Anderson Cancer Center, Houston
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
RekruttererFase 1
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
Telephone Support in Advanced Gastrointestinal Cancer
Rekrutterer
- MD Anderson Cancer Center, Houston
Improving Comprehensive Care of Cancer Patients
RekruttererFrivillige helsepersonell ønskes velkommen
- Baylor College of Medicine, Houston
BOLSTER: Learning New Skills to Thrive
Rekrutterer
- The University of Texas MD Anderson Cancer Center, Houston
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
RekruttererObservasjonsstudie
- M D Anderson Cancer Center, Houston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekruttererFase 1
- University of Texas, MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruttererFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Molecular Epidemiology of Biliary Tree Cancers
RekruttererObservasjonsstudie
- M D Anderson Cancer Center, Houston
Traction vs. No Traction in Colonic ESD
Rekrutterer
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
Rekrutterer
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
Mage-tarmkreft-studier i andre byer
- Boston, MA15 studier
- New York City, NY12 studier
- Nashville, TN10 studier
- Los Angeles, CA9 studier
- Dallas, TX8 studier
- Cincinnati, OH8 studier
- Durham, NC8 studier
- Baltimore, MD8 studier
- Arlington, VA8 studier
- Baldwin Park, CA7 studier
- Seattle, WA7 studier
- San Antonio, TX7 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.